← Back to Search

Web-Based Tool for Cardiovascular Care in Prostate Cancer

N/A

Recruiting

Led By Vivek Narayan, MD

Research Sponsored by Vivek Narayan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Men with prostate cancer over 18 years of age who are currently receiving or will be receiving treatment with at least 6 months of ADT

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 18 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to improve cardiovascular care for prostate cancer patients undergoing ADT by providing them with a web-based tool to educate them about their individual cardiovascular risks and how to manage them. The study will test

Who is the study for?

This trial is for men over 18 with prostate cancer who are currently on or will start androgen deprivation therapy (ADT) for at least six months. Participants need to be able to read and understand English.

What is being tested?

The CARE-PC study is testing a web-based application designed to educate prostate cancer patients about their cardiovascular risks associated with ADT, provide personalized risk assessments, and offer guidelines for risk reduction.

What are the potential side effects?

Since this trial involves the use of an educational web tool rather than a medical treatment, there are no direct side effects related to medication. However, participants may experience stress or anxiety from learning about their cardiovascular risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a man over 18 with prostate cancer and will be on hormone therapy for at least 6 months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

CARE-PC Web-Based Application Completion Rate

Secondary study objectives

Patient acceptance and perception of the web-based application

Percent accuracy of patient-derived CV- and prostate cancer-related data elements

Prevalence of CV risk factors/disease at the time of CARE-PC web-based application participation

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Men With Prostate Cancer Planned for Receiving ADTExperimental Treatment1 Intervention

Men with prostate cancer \> 18 years of age who are currently receiving or will be receiving treatment with ≥ 6 months of systemic androgen deprivation therapy (ADT).

0 / 1Eligibility criteria met